Showing results (311-320 of 557) with videos related to
Sort By:
Pageof 56
Annals of Nuclear Medicine|December 22, 2020
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific membrane antigenKai Huang, Imke Schatka, Julian M M Rogasch, et al.Cellular & Molecular Immunology|February 1, 2011
The effects of Spirulina on anemia and immune function in senior citizensCarlo Selmi, Patrick S C Leung, Laura Fischer, et al.Hepatology (Baltimore, Md.)|July 31, 2007
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosisMonica Miozzo, Carlo Selmi, Barbara Gentilin, et al.Journal of Autoimmunity|July 4, 2012
Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshopCarlo Selmi, Patrick S C Leung, David H Sherr, et al.Autoimmunity|January 8, 2008
Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosisSabine Oertelt-Prigione, Tin K Mao, Carlo Selmi, et al.Lancet (London, England)|February 21, 2004
Frequency of monosomy X in women with primary biliary cirrhosisPietro Invernizzi, Monica Miozzo, Pier Maria Battezzati, et al.Plos One|July 21, 2010
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritisMaria Cristina De Rosa, Bruno Giardina, Caterina Bianchi, et al.Respiratory Research|August 19, 2005
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosisMaria De Santis, Silvia Bosello, Giuseppe La Torre, et al.Arthritis Research & Therapy|November 19, 2008
Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritisFrancesco Ria, Romina Penitente, Maria De Santis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.Pageof 56